Continued from page 1
IHPC is currently utilized by oncologists throughout 8 centers Nationwide, with treatment of an average of 40-50 cases annually. According to Dr. Shen, one study was performed in Europe of a randomized differential of Systemic (traditional) Chemotherapy as opposed to IHPC, and found favor towards Intraperitoneal Heated Chemotherapy. Dr. Shen optimistically explained that more cases could be substantially helped if caught in early stages. (3) Dr. Perry Shen is
Assistant Professor in
Department of General Surgery at Wake Forest University School of Medicine in Winston-Salem, NC.
As with all medical breakthroughs,
health hope of mankind rests in
hands of researchers and medical communities across
globe. While modern technology is steadily improving overall life expectancies, it is also important to remember that if we choose to live healthier, happier lives - prevention is key. In closing, I commend Dr. Shen and his medical research staff for
advancement and hopeful promise of enhancing patient's lives through committed research and human compassion.
© C. Bailey-Lloyd 2004 © Lady Camelot
C. Bailey-Lloyd / Lady Camelot currently serves as
Public Relations' Director and a Staff Writer for www.holisticjunction.com To contact Ms. Bailey-Lloyd, email her at ladycamelot@holisticjunction.com
References:
1) Ann Surg Oncol - 2004; 11(2):178-186 - Factors Predicting Survival After Intraperitoneal Hyperthermic Chemotherapy with Mitomycin C after Cytoreductive Surgery for Patients with Peritoneal Carcinomatosis - Perry Shen, MD, Edward A. Levine, MD, Jason Hall, MD, Doug Case, PhD, Greg Russel, MS; Cytoreductive Surgery - © 2003 American Medical Association
2) Ann Surg Oncol - 2004; 11(2):178-186 - Factors Predicting Survival After Intraperitoneal Hyperthermic Chemotherapy with Mitomycin C after Cytoreductive Surgery for Patients with Peritoneal Carcinomatosis - Perry Shen, MD, Edward A. Levine, MD, Jason Hall, MD, Doug Case, PhD, Greg Russel, MS; Cytoreductive Surgery - © 2003 American Medical Association
3) Shen, Perry MD., Biography: Clinical Interests: Surgical Oncology, Hepatic Tumors, Radiofrequency ablation, Sarcoma and Melanoma Surgery - Research Interests: Metastic Liver lesions, radiofrequency ablation, intraoperative ultrasound.
4) Wake Forest University - Academic Medical Center & School of Medicine www.bgsm.edu/school/ 5) American Medical Association
[All work by author is copyright protected. If you would like to use this article, please contact
author for permission.]

C. Bailey-Lloyd currently resides as the Public Relations' Director and staff writer for www.holisticjunction.com and